Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 21 Neoplasms 6 Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Recurrence 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Cancer 4 Uveal Melanoma 3 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Liver Neoplasms 3 Colonic Neoplasms 3 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Glioma 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Basal Cell 2 Brain Neoplasms 2

Interventions

Injections 27 Carboplatin 18 Docetaxel 14 pembrolizumab 13 Paclitaxel 12 Bevacizumab 10 durvalumab 8 Nivolumab 8 Cisplatin 8 Fluorouracil 7 Pemetrexed 6 Oxaliplatin 6 Leucovorin 6 trifluridine tipiracil drug combination 5 toripalimab 5 tislelizumab 5 linifanib 5 Capecitabine 5 zimberelimab 4 talazoparib 4 olaparib 4 fludarabine 4 Panobinostat 4 Itraconazole 4 Irinotecan 4 Gemcitabine 4 Everolimus 4 tremelimumab 3 sotorasib 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumors × relatlimab × Clear all

NCT05498480 2024-02-20

RELATIVITY-111

Bristol-Myers Squibb

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡